In a first, Glenmark launches Lobeglitazone in India for uncontrolled type-II diabetes in adults EP News Bureau Oct 6, 2022 With this launch, the company aims to improve glycemic levels in uncontrolled diabetics and create a new pathway to treat insulin…
Glenmark launches Teneligliptin + Pioglitazone Fixed-Dose Combination drug for type-II diabetes in… EP News Bureau Apr 27, 2022 The company has launched this FDC under the brand name Zita Plus Pio, which contains Teneligliptin (20 mg) + Pioglitazone (15 mg),…
